Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up.

Purpose: The aim of the study was to evaluate the effect of 3 subconjunctival bevacizumab injections in patients with an early corneal pterygium recurrence.

Methods: This study was a nonrandomized single center trial. Patients with an early corneal pterygium recurrence were selected.